The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. At the same time, more barriers to success are emerging with requirements for increasingly complex clinical trials, continuous regulatory changes, evolving payer conditions, and more restrictive access to HCPs. It’s..

Kwame Ulmer is a 12 year veteran of the FDA and currently works as a regulatory strategist and investor. You will learn how to develop a regulatory strategy, maximize your interactions with the FDA and efficiently get your product approved. The presentation is geared towards helping C-Suite executives understand the key levers to drive premarket..

Join the live webinar with Laura Haldane as she introduces SciLeads, an innovative life science and applied research lead generation platform. SciLeads works with bioscience companies in California and around the world to accelerate their sales by enabling them to quickly find and engage with targeted and funded leads, and develop outreach strategies. Also joining..

MDMA's 2022 FDA Forum will feature senior officials from FDA and industry and focus on the key regulatory issues impacting the medical device industry. Designed specifically for medical device regulatory professionals and executive decision makers, MDMA's FDA Forum promises to deliver key regulatory insights and preview trends that will impact your regulatory and business strategies...

Join us for a discussion on improving patient access to healthcare in under-represented communities, the importance of diversifying clinical trials, and exploring rare diseases that affect Black, Indigenous, and People of Color (BIPOC) women. Register»